Story
Kadoya Sesame Mills Stock Hits Record High on Private Equity Tender Offer

Summary
Shares of the Japanese sesame oil maker surged after an entity linked to private equity firm Integral launched a public tender offer to take the company private. The stock is trading above the offer price, signaling market expectations of a revised bid.
Shares of Kadoya Sesame Mills (TSE:2612) surged +13.7% to a record high of ¥2,751 after an entity affiliated with Japanese private equity firm Integral launched a public tender offer to acquire the company.
The Buyout Offer
ITG-G Holdings, an entity connected to Integral, has formally commenced a tender offer for all outstanding common shares of the sesame oil producer, according to a report from Investing.com. The offer is set at a price of ¥2,514 per share.
The buyout window for shareholders to tender their shares runs from September 14 through October 30, 2026. Kadoya's board of directors has expressed its support for the transaction and is recommending that shareholders accept the offer, indicating a clear path toward the company going private.
Market Reaction and Arbitrage
The stock's closing price of ¥2,751 is significantly above the ¥2,514 offer price. This premium suggests that market participants and arbitrageurs anticipate that the buyout terms may be revised upward before the offer period concludes.
This strong company-specific move occurred against a modestly positive backdrop for the broader Japanese market, with the Nikkei 225 index rising 0.8% during the session.
AdSteps Toward Delisting
In a move characteristic of a company preparing to delist from a public exchange, Kadoya announced on September 14 that it would be taking steps to alter its shareholder return policy.
The company plans to:
- Eliminate its annual dividend for the fiscal year ending March 2027.
- Abolish its shareholder benefit program.
These actions are consistent with the company's transition from a publicly traded entity to a privately held one under the new ownership structure.
Read next
More on Stocks
Large Bullish Options Trade Bets on BioMarin Stock Reaching $100 by April 2027
A significant options trade on BioMarin Pharmaceutical suggests a trader is betting on the stock to rise more than 37% by April 2027, a move supported by unusual volatility signals.

GlobalFoundries Stock Rallies on US-Japan Fab Report, Marvell AI Deal
Shares of the semiconductor manufacturer jumped after a report detailed negotiations for a multi-billion dollar U.S. factory backed by Japan, alongside a new manufacturing agreement with Marvell for AI components.

Lyft Stock Slips After Guggenheim Downgrade on Growth Concerns
Guggenheim downgraded Lyft to Neutral from Buy and cut its price target to $16, citing a reduced growth forecast and uncertainty from an upcoming CFO change.

SpaceX Considers Buying Data From Failed Startups for AI Development, Report Says
Elon Musk's SpaceX is reportedly holding internal discussions to acquire customer and operational data from struggling or defunct startups, a move aimed at sourcing affordable data to train its artificial intelligence models.